Information for Dispensers

New! Effective July 1, 2018

Dear Prescription Data Submitter,

The PMP Clearinghouse has been updated to the ASAP version 4.2A. This update includes the functionality to capture exemption codes for opioid prescriptions exceeding 100 morphine milligram equivalents, and the ICD-10 codes for the palliative care exemption.

The updated user guide outlining the ASAP 4.2A specifications, as well as a guide that crosswalks the Maine exemption codes to the ASAP 4.2A Treatment Codes is available on the Maine PMP website and is available in the Quick Links section of your PMP dashboard.

IMPORTANT CHANGES TO NOTE:

• DSP05 – Date Filled
This field should reflect the date the prescription left the pharmacy. This is to ensure that the patient report accurately reflects the date the patient received the prescription.
• DSP24 – Treatment Type
Required for opioid prescriptions exceeding 100 MME - Guide/Crosswalk (PDF)
• DSP25 – Diagnosis Code
Required when Palliative Care Exemption Code is utilized for opioid prescriptions exceeding 100 MME

You may begin reporting in ASAP 4.2A now, as the system will be accepting both ASAP 4.2 and ASAP 4.2A.

Effective July 1, 2018, the system will only accept ASAP 4.2A. (14-118 C.M.R. ch. 11, §5(C, 1, n.))

For additional information, please contact the PMP Team at SAMHS.PMP@maine.gov or by phone at (207) 287-2595 option 2.

For technical assistance, please contact the Appriss Clearinghouse helpdesk at (844) 463-4767

Thank you for your continued help preventing prescription drug misuse, abuse and diversion.

Sincerely,

The Prescription Monitoring Program Team

IMPORTANT CHANGES TO NOTE:

• DSP05 – Date Filled
This field should reflect the date the prescription left the pharmacy. This is to ensure that the patient report accurately reflects the date the patient received the prescription.
• DSP24 – Treatment Type
Required for opioid prescriptions exceeding 100 MME (see attached guide/crosswalk)
• DSP25 – Diagnosis Code
Required when Palliative Care Exemption Code is utilized for opioid prescriptions exceeding 100 MME

You may begin reporting in ASAP 4.2A now, as the system will be accepting both ASAP 4.2 and ASAP 4.2A.

Effective July 1, 2018, the system will only accept ASAP 4.2A. (14-118 C.M.R. ch. 11,  5(C, 1, n.))

For additional information, please contact the PMP Team at SAMHS.PMP@maine.gov or by phone at (207) 287-2595 option 2.

For technical assistance, please contact the Appriss Clearinghouse helpdesk at (844) 463-4767

Thank you for your continued help preventing prescription drug misuse, abuse and diversion.

Sincerely,

The Prescription Monitoring Program Team

Opioid Dispensing Clarifications
Effective August 1, 2017, all opioid medications must be electronically prescribed.
A pharmacist is NOT required to verify that a practitioner has a waiver from the requirement to electronically prescribe or properly falls under one of the other exceptions from the requirement to electronically prescribe. It is the responsibility of the practitioner to ensure their compliance with the electronic prescribing mandate. Pharmacists may continue to dispense medications from otherwise valid written, oral or fax prescriptions that are consistent with current laws and regulations.


The Department will be conducting periodic audits. If a prescriber is identified as repeatedly submitting written prescriptions to a pharmacy, that provider may be at risk for professional discipline.


For more additional information regarding opioid dispensing, please review Opioid Dispensing Clarifications

Maine PMP Clearinghouse
Effective Tuesday, December 20, 2016, dispensers must submit data to the PMP Clearinghouse.
Registration
The Data Submission Dispenser Guide (PDF) explains the process to register and transmit data to the Appriss Clearinghouse. The Clearinghouse is for data submission only. If you have any questions or concerns regarding how to make this change, please contact support directly at 1-844-4ME-4PMP (1-844-463-4767). Technical assistance is available 24 hours a day, 7 days a week, 365 days a year.


If you are currently registered with the PMP Clearinghouse as a data submitter for another state, you DO NOT need to re-register. Simply follow these three simple steps:

  1. Log in to the PMP Clearinghouse (https://pmpclearinghouse.net)
  2. Navigate to Account -> Multi State Approval
  3. Select from the list of states you want to submit data to
    • A request is sent to the PMP Administrator of each selected state(s) for approval
    • When your request has been approved by the Maine PMP Administrator, the status will turn green (it is yellow when a request is pending)

Whether you are registering for the first time or you are an existing user, your request to submit to the Maine PMP will remain in a “pending approval” status until the state administrator approves your account.


Information for Dispensers
The Maine PMP is intended to be a tool for healthcare professionals to promote and improve patient wellbeing through improved coordination of care and the prevention and detection of prescription drug misuse, abuse, and diversion. It is not meant to interfere with the legitimate medical use of controlled substances.


Data Submission
Data must be submitted no later than the close of business on the next business day of the controlled substance being dispensed (as defined in 32 MRS §13702-A). The data must be in ASAP 4.2 format for all transactions involving Schedule II, III, and IV drugs. Information on how to upload dispensed medications to Maine’s PMP can be found on the Data Submission Dispenser Guide

Maine adheres to the Federal Drug Enforcement Agency (DEA) list of scheduled drugs.

The Office of Substance Abuse and Mental Health Services (SAMHS) requests that dispensers provide the cleanest data possible, particularly in relation to the prescriber’s DEA number. If errors are found dispensers are required to correct them in a timely fashion. Please help make this system reliable. The reports will only be as good as the data that are collected. The PMP software vendor can do some data cleaning but is limited in their capacity to do so.
For any technical issues, assistance, or questions about submitting data or making electronic corrections to the PMP, please contact Appriss’s Technical Support at 1-844-4ME-4PMP (1-844-463-4767), or create an online support request.

Pharmacy Compliance and Waiver
Pursuant to 22 M.S.R. §7249, all Maine licensed pharmacies are required to upload all dispensed Schedule II, III, and IV drugs on a daily basis. If no transactions for Schedule II, III, or IV drugs occurred during a reporting period, the pharmacy must submit a “no activity” report unless a waiver has been approved by SAMHS. Failure to submit information as required is subject to discipline by the Maine Board of Pharmacy (32 M.S.R. c.117.4). 

Pharmacies may apply for a waiver from electronic submission of controlled substance prescription information under certain circumstances.  All pharmacies must upload all dispensed controlled substances daily until approval of the waiver request. Waiver Form and Process

Using Reports
SAMHS is aware that Patient History Reports may create tough decisions for pharmacists dealing with customers who appear to be involved in questionable activity or are receiving conflicting or numerous prescriptions by multiple physicians. 

By State law (32 M.R.S. §13795(2)), a pharmacist may exercise discretion and refuse to fill any prescription or dispense any drug if they are unsatisfied as to the legitimacy or appropriateness of any prescription presented without any fear of disciplinary action from the Board of Pharmacy or from civil liability. 

SAMHS does not presume to tell dispensing pharmacies what to do with prescription monitoring information. Pharmacists should use their best professional judgment on each case as it presents itself. SAMHS suggests contacting and communicating with the prescribers connected to the customer for coordination and collaboration. The objective is to identify possible problems, get people the treatment they need, curb illicit use of prescription drugs, and provide appropriate patient care.


Confidentiality/HIPAA
Although SAMHS programs are not covered by HIPAA, they are covered by other confidentiality laws. Both SAMHS and Appriss, our business partner that works with the PMP database, are required to keep consumer information private and secure. Access to the PMP database is limited to users who are registered with SAMHS, as required by state law. A registered user does not need to seek permission from a consumer to access the PMP.


Questions/Contact
SAMHS is committed to creating a good working relationship with all healthcare providers using the PMP system to provide better care to the people of Maine and address any prescription drug misuse, abuse, and diversion. Please feel free to contact SAMHS with your questions and concerns. Appriss staff members are also available to answer any technical questions about the PMP web portal, log-in, or data submission.


SAMHS:
Phone: (207) 287-2595
Email: SAMHS.PMP@maine.gov
Staff: Johanna Buzzell, Prescription Monitoring Program Coordinator


Appriss Technical Support:
Phone: 1-844-4ME-4PMP (1-844-463-4767)
Support Request: Create an online support request

 

For more information:

If you haven't found what you're looking for, visit: